LQDA Liquidia Corporation Operatsion marja

Liquidia Technologies (LQDA) - korporativ logo

Liquidia Corporation (LQDA) biznes barqarorligi tashqi ta'minot zanjirlariga bog'liqligi va geosiyosiy xatarlar bilan cheklangan. Operatsion marja foyda dinamikasini aks ettiradi, bunda 47.10 bazaviy qiymat sifatida qayd etilgan. Kompaniyaning o'sishi Treprostinil tijoratlashtirilishi va patent muvaffaqiyatlariga tayangan bo'lsa-da, uning yagona terapevtik sohaga kritik darajada konsentratsiyasi umumiy xatarlarni kamaytirish uchun portfelni zudlik bilan kengaytirishni taqozo etadi.

LQDA: liquidia.com Operatsion foyda bo'yicha sotuv rentabelligi 04.07.2022 - 20.11.2026

Liquidia (LQDA) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

Kompaniyaning fundamental baholanishi:Liquidia Inc., LQDA
liquidia.com tayyor mahsulotlari

Operatsion marja moliyaviy va soliq majburiyatlari hisobga olinishidan oldin xarajatlarni boshqarish samaradorligining fundamental ko'rsatkichi bo'lib, umumiy tushumga nisbatan asosiy operatsiyalardan olingan foyda ulushini belgilaydi. Operatsion marja xronologiyasini tahlil qilish orqali investor Liquidia Corporation (LQDA) kompaniyasining huquqiy nizolar hal etilganidan va pulmonar gipertenziya terapiyasi bozorida Yutrepia savdolari kengayganidan so'ng daromadli holatga o'tganini ko'radi.

Raqobatdosh kompaniyalar tahlili

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|PRGO - Operatsion rentabellik|Alvotech Corp (ALVO) - Sotuvning operatsion marjasi|Galapagos N.V. (GLPG) - Operatsion rentabellik|anipharmaceuticals.com - Operatsion foyda normasi|Sotuvning operatsion marjasi MNKD|AMPH: Operatsion foyda normasi|Operatsion rentabellik pacira.com (PCRX)|Operatsion marja ARS Pharma (SPRY)|Theravance Biopharma - Sotuvning operatsion marjasi|Operatsion foyda koeffitsiyenti AQST (Aquestive Therapeutics)|SCPH: Sotuvning operatsion marjasi|Sotuvning operatsion rentabelligi Tectonic Therapeutic|TNXP: Operatsion marja|SXT China (SXTC) - Operatsion marja|Operatsion rentabellik eupraxiapharma.com|BioHarvest Sciences (BHST) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Invizyne (EXOZ)|ORMP - Sotuvning operatsion rentabelligi|Operatsion marja ENTX (Entera Bio)|Operatsion foyda bo'yicha marjinallik MindWalk Therapeutics|ABVC: Sotuvning operatsion marjasi|CPIX - Operatsion marja|QNTM (Quantum BioPharma) - Sotuvning operatsion marjasi|Operatsion foyda marjasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operatsion marja|Operatsion marja ranitherapeutics.com|Operatsion rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Operatsion foyda bo'yicha sotuv rentabelligi|lexariabioscience.com - Sotuvning operatsion marjasi|Operatsion marja Pulmatrix Inc PULM|Pheton Holdings - Operatsion marja|Operatsion foyda marjasi APM|Lyra Therapeutics, Inc. (LYRA) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Impact BioMedical, Inc. (IBO)|Operatsion rentabellik TNF Pharma|YCBD: Operatsion foyda normasi|Operatsion marja PRFX|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.